Literature DB >> 33209500

Comparison between B-mode ultrasonography and contrast-enhanced ultrasonography for the surveillance of early stage pancreatic cancer: a retrospective study.

Jin Xu1, Meng Zhang1, Gang Cheng2.   

Abstract

BACKGROUND: Contrast-enhanced ultrasonography (CE-US) brings a higher signal-to-noise ratio and a higher sensitivity for slow flow than traditional B-mode ultrasonography (US). However, it remains unclear whether CE-US is also superior to B-mode US in detecting early-stage pancreatic cancer (PC).
METHODS: This was a retrospective study enrolling patients suspected of pancreatic insufficiency between June 2015 and December 2019. Enrolled patients successively received B-mode US and CE-US examinations, and some their demographic and clinical data were collected. The diagnostic capacity of the two examinations was calculated and receiver operating characteristic (ROC) curves was used to compare the area under the curve (AUC). A subgroup analysis was performed to explore the effects of tumor size on the diagnostic accuracy of B-mode US and CE-US.
RESULTS: There were 128 patients enrolled in this study; 74 patients were diagnosed as early-stage PC patients and the remaining 54 were diagnosed with benign pancreatic lesions. The mean size of the PC was 17.8±4.9 mm. The results revealed that 68 of the 74 PC patients were correctly diagnosed by CE-US, and all 54 patients with benign pancreatic lesions were also correctly diagnosed. Meanwhile, only 55 of the 74 PC patients and 50 of the 54 patients with benign pancreatic lesions were diagnosed correctly using B-mode US. The ROC curve showed that the AUCs of CE-US and B-mode US were 0.959 and 0.835, respectively. According to the subgroup analysis, CE-US exhibited better accuracy than B-mode US for smaller tumors (size <20 mm, P=0.002; size <10 mm, P=0.043; size <5 mm, P=0.025).
CONCLUSIONS: CE-US was clearly superior to the conventional B-mode US in detecting early-stage PC, especially smaller sized PC. 2020 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  B-mode ultrasonography (B-mode US); contrast-enhanced ultrasonography (CE-US); early stage pancreatic adenocarcinoma; surveillance

Year:  2020        PMID: 33209500      PMCID: PMC7657828          DOI: 10.21037/jgo-20-412

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  20 in total

1.  Effectiveness of Contrast-Enhanced Ultrasonography for the Characterization of Small and Early Stage Pancreatic Adenocarcinoma.

Authors:  Sachiko Tanaka; Junko Fukuda; Miho Nakao; Tatsuya Ioka; Reiko Ashida; Rena Takakura; Suetsumi Okagaki; Kazuhiro Katayama; Kazuyoshi Ohkawa; Kenji Ikezawa; Shigenori Nagata
Journal:  Ultrasound Med Biol       Date:  2020-06-08       Impact factor: 2.998

2.  The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations.

Authors:  Fabio Piscaglia; Luigi Bolondi
Journal:  Ultrasound Med Biol       Date:  2006-09       Impact factor: 2.998

3.  Contrast-enhanced ultrasonography and blue dye methods in detection of sentinel lymph nodes following neoadjuvant chemotherapy in initially node positive breast cancer.

Authors:  Xiufeng Wu; Lina Tang; Weiqin Huang; Shixin Huang; Wei Peng; Dan Hu
Journal:  Arch Gynecol Obstet       Date:  2020-06-29       Impact factor: 2.344

Review 4.  Palliative chemotherapy in pancreatic cancer-treatment sequences.

Authors:  Rami Abbassi; Hana Algül
Journal:  Transl Gastroenterol Hepatol       Date:  2019-08-01

5.  Comparison between CT and CEUS in the diagnosis of pancreatic adenocarcinoma.

Authors:  M D'Onofrio; S Crosara; M Signorini; R De Robertis; S Canestrini; F Principe; R Pozzi Mucelli
Journal:  Ultraschall Med       Date:  2012-09-21       Impact factor: 6.548

6.  Comparison of IV contrast-enhanced sonography and histopathology of pancreatic cancer.

Authors:  Kenji Takeshima; Takashi Kumada; Hidenori Toyoda; Seiki Kiriyama; Makoto Tanikawa; Hideo Ichikawa; Toshiaki Kawachi; Sadanobu Ogawa
Journal:  AJR Am J Roentgenol       Date:  2005-11       Impact factor: 3.959

7.  Assessment of real-time and quantitative changes in renal hemodynamics in healthy overweight males: Contrast-enhanced ultrasonography vs para-aminohippuric acid clearance.

Authors:  Marcel H A Muskiet; Anna L Emanuel; Mark M Smits; Lennart Tonneijck; Rick I Meijer; Jaap A Joles; Erik H Serné; Daniël H van Raalte
Journal:  Microcirculation       Date:  2019-08-26       Impact factor: 2.628

8.  Three-dimensional contrast-enhanced ultrasonography of intraductal papillary mucinous neoplasms of the pancreas: a comparison with magnetic resonance imaging.

Authors:  Raffaele Pezzilli; Carla Serra; Lucia Calculli; Fabio Ferroni; Maria Teresa Iammarino; Riccardo Casadei
Journal:  Pancreas       Date:  2013-10       Impact factor: 3.327

Review 9.  Imaging diagnosis of pancreatic cancer: a state-of-the-art review.

Authors:  Eun Sun Lee; Jeong Min Lee
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

10.  Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer.

Authors:  Michele Amadori; Domenico Barone; Emanuela Scarpi; Devil Oboldi; Elena Amadori; Gianfranco Bandi; Alice Rossi; Fabio Ferroni; Angela Ragazzini; Andrea Casadei Gardini; Giovanni Luca Frassineti; Giampaolo Gavelli; Alessandro Passardi
Journal:  Eur Radiol       Date:  2018-02-07       Impact factor: 5.315

View more
  1 in total

1.  Deep learning radiomics based on contrast-enhanced ultrasound images for assisted diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis.

Authors:  Tong Tong; Jionghui Gu; Dong Xu; Ling Song; Qiyu Zhao; Fang Cheng; Zhiqiang Yuan; Shuyuan Tian; Xin Yang; Jie Tian; Kun Wang; Tian'an Jiang
Journal:  BMC Med       Date:  2022-03-02       Impact factor: 8.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.